Compare Stocks: LITS, DFDV, HSDT, and UPXI

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
DFDV DeFi Development	$4.58 -2.7%	$4.56	$2.44 ▼ $18.28	$141.21M	-3.59	1.32 million shs	564,033 shs
HSDT Solana	$2.46 -3.3%	$2.23	$1.18 ▼ $17.97	$149.12M	1.11	377,062 shs	99,602 shs
LITS Lite Strategy	$1.25 -2.0%	$1.09	$0.69 ▼ $2.97	$36.34M	0.17	405,698 shs	353,550 shs
UPXI Upexi	$1.07 -1.4%	$1.01	$0.54 ▼ $7.30	$93.91M	-0.26	3.76 million shs	743,064 shs

10 Stocks Powering The Next AI Boom

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
DFDV DeFi Development	-5.42%	-12.29%	-19.76%	+55.96%	-69.11%
HSDT Solana	-4.51%	-3.05%	+13.39%	+38.80%	-86.01%
LITS Lite Strategy	-9.93%	-3.79%	+11.40%	+27.90%	-48.16%
UPXI Upexi	-5.26%	-5.26%	+0.93%	+32.11%	-84.68%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
DFDV DeFi Development	$4.58 -2.7%	$4.56	$2.44 ▼ $18.28	$141.21M	-3.59	1.32 million shs	564,033 shs
HSDT Solana	$2.46 -3.3%	$2.23	$1.18 ▼ $17.97	$149.12M	1.11	377,062 shs	99,602 shs
LITS Lite Strategy	$1.25 -2.0%	$1.09	$0.69 ▼ $2.97	$36.34M	0.17	405,698 shs	353,550 shs
UPXI Upexi	$1.07 -1.4%	$1.01	$0.54 ▼ $7.30	$93.91M	-0.26	3.76 million shs	743,064 shs

10 Stocks Powering The Next AI Boom

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
DFDV DeFi Development	-5.42%	-12.29%	-19.76%	+55.96%	-69.11%
HSDT Solana	-4.51%	-3.05%	+13.39%	+38.80%	-86.01%
LITS Lite Strategy	-9.93%	-3.79%	+11.40%	+27.90%	-48.16%
UPXI Upexi	-5.26%	-5.26%	+0.93%	+32.11%	-84.68%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
DFDV DeFi Development	2.00	Hold	$10.40	126.98% Upside
HSDT Solana	2.25	Hold	$4.00	62.93% Upside
LITS Lite Strategy	1.00	Sell	N/A	N/A
UPXI Upexi	2.00	Hold	$5.00	369.48% Upside

Current Analyst Ratings Breakdown

Latest LITS, DFDV, HSDT, and UPXI Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
9/24/2026	LITS Lite Strategy	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
9/22/2026	DFDV DeFi Development	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Hold (C) ➝ Sell (D-)
9/22/2026	HSDT Solana	B. Riley Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$3.50 ➝ $4.00
9/18/2026	UPXI Upexi	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Overweight	$2.00
9/10/2026	DFDV DeFi Development	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Overweight	$4.70 ➝ $10.40
9/10/2026	UPXI Upexi	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Overweight	$1.30 ➝ $2.00
9/8/2026	LITS Lite Strategy	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
9/4/2026	UPXI Upexi	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)
9/3/2026	HSDT Solana	B. Riley Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy
9/3/2026	HSDT Solana	B. Riley Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$2.50 ➝ $3.50
8/21/2026	LITS Lite Strategy	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)

(Data available from 10/8/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
DFDV DeFi Development	$11.39M	12.47	$0.82 per share	5.60	$3.12 per share	1.47
HSDT Solana	$6.02M	24.77	N/A	N/A	$6.88 per share	0.36
LITS Lite Strategy	$65.30M	0.58	N/A	N/A	$1.22 per share	1.02
UPXI Upexi	$25M	3.76	N/A	N/A	($0.68) per share	-1.57

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
DFDV DeFi Development	-$73.79M	-$9.98	N/A	N/A	N/A	-1,319.45%	17.97%	5.02%	N/A
HSDT Solana	-$40.89M	-$30.32	N/A	18.88	N/A	-1,302.78%	-41.86%	-18.53%	11/17/2026 (Estimated)
LITS Lite Strategy	-$71.15M	-$1.98	N/A	N/A	N/A	N/A	-97.27%	-95.90%	N/A
UPXI Upexi	-$246.07M	-$4.06	N/A	N/A	N/A	-984.34%	-157.49%	-22.60%	11/11/2026 (Estimated)

Latest LITS, DFDV, HSDT, and UPXI Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
9/28/2026	Q4 2026	LITS Lite Strategy	N/A	-$0.38	N/A	-$0.38	N/A	N/A
9/17/2026	Q4 2026	UPXI Upexi	-$0.11	-$0.10	+$0.01	-$2.3720	$5.80 million	$6.52 million
8/14/2026	Q2 2026	HSDT Solana	-$0.02	-$0.38	-$0.36	-$0.38	$3.50 million	$2.53 million
8/12/2026	Q2 2026	DFDV DeFi Development	N/A	-$0.21	N/A	-$1.00	N/A	$3.31 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
DFDV DeFi Development	N/A	N/A	N/A	N/A	N/A
HSDT Solana	N/A	N/A	N/A	N/A	N/A
LITS Lite Strategy	N/A	N/A	N/A	N/A	N/A
UPXI Upexi	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
DFDV DeFi Development	12.53	1.27	1.27
HSDT Solana	N/A	13.31	13.31
LITS Lite Strategy	N/A	5.74	5.74
UPXI Upexi	N/A	1.64	1.64

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
DFDV DeFi Development	0.48%
HSDT Solana	18.63%
LITS Lite Strategy	52.38%
UPXI Upexi	5.68%

Insider Ownership

Company	Insider Ownership
DFDV DeFi Development	23.61%
HSDT Solana	14.40%
LITS Lite Strategy	1.60%
UPXI Upexi	9.00%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
DFDV DeFi Development	16	31.00 million	23.68 million	N/A
HSDT Solana	21	60.74 million	51.99 million	Not Optionable
LITS Lite Strategy	100	30.41 million	29.92 million	N/A
UPXI Upexi	10	88.18 million	80.24 million	Optionable

LITS, DFDV, HSDT, and UPXI Headlines

Recent News About These Companies

Analyzing Flywire (NASDAQ:FLYW) and Upexi (NASDAQ:UPXI)

October 7 at 5:28 AM | americanbankingnews.com

Upexi to Participate in Upcoming October Investor Conferences

October 6 at 8:00 AM | globenewswire.com

Upexi Earnings Call: High-Stakes Bet on Solana

September 22, 2026 | tipranks.com

UPEXI (NASDAQ: UPXI) Reports $25M Revenue, $246M Net Loss, Highlights Growth in Digital Asset Revenue

September 20, 2026 | kalkinemedia.comK

Upexi (NASDAQ:UPXI) Stock Rating Lowered by Wall Street Zen

September 20, 2026 | marketbeat.com

Analysts Offer Insights on Communication Services Companies: Upexi (UPXI) and AT&T (T)

September 19, 2026 | theglobeandmail.com

Upexi expects staking revenue to more than cover ongoing cash expenses as it cuts headcount to 10 and refinances debt to 7.5%

September 18, 2026 | seekingalpha.com

Upexi (UPXI) Q4 2026 Earnings Call Transcript

September 18, 2026 | finance.yahoo.com

Upexi Target of Unusually Large Options Trading (NASDAQ:UPXI)

September 18, 2026 | marketbeat.com

Upexi (NASDAQ:UPXI) Receives Overweight Rating from Cantor Fitzgerald

September 18, 2026 | marketbeat.com

Upexi Q4 Earnings Call Highlights

September 17, 2026 | marketbeat.com

Upexi (UPXI) Stock Falls on Quarterly Earnings

September 17, 2026 | quiverquant.comQ

Upexi Reports Fiscal 2026 Results, Digital Asset Revenue of $17.4 Million and 2.34 Million SOL Held at Year-End

September 17, 2026 | quiverquant.comQ

Upexi Reports Financial Results for Fiscal Year Ended June 30, 2026

September 17, 2026 | globenewswire.com

Upexi to Host Fiscal Year 2026 Earnings Call on Thursday, September 17th at 5:30 P.M. ET

September 15, 2026 | globenewswire.com

Upexi Amends BitGo Credit Facility

September 14, 2026 | globenewswire.com

Wall Street Zen Upgrades Upexi (NASDAQ:UPXI) to "Hold"

September 12, 2026 | marketbeat.com

Cantor Fitzgerald Boosts Upexi (NASDAQ:UPXI) Price Target to $2.00

September 10, 2026 | marketbeat.com

Upexi to Participate in FT Partners FinTech Conference 2026 on September 15th

September 8, 2026 | globenewswire.com

Upexi Faces Nasdaq Non-Compliance on Minimum Bid Price

July 31, 2026 | tipranks.com

Upexi Insider Trading Activity | NASDAQ:UPXI | Benzinga

July 7, 2026 | benzinga.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

LITS, DFDV, HSDT, and UPXI Company Descriptions

DeFi Development NASDAQ:DFDV

$4.57 -0.14 (-2.91%)

As of 10:59 AM Eastern

We are a B2B fintech marketplace connecting commercial property borrowers and lenders with a human touch. We seek to revolutionize the commercial real estate lending market by making it hyper-efficient, transparent, and accessible to all rather than the few. Through our online platform, we provide technology that connects commercial mortgage borrowers looking for capital to refinance, build, or purchase commercial property, including, but not limited to, apartment buildings, to commercial property lenders. Borrowers include, but are not limited to, owners, operators, and developers of commercial real estate including multifamily properties and most recently, a growing segment of small business owners, which we believe represents a significant growth opportunity. Lenders include small banks, credit unions, REITs, Fannie Mae® and Freddie Mac® multifamily lenders, FHA® multifamily lenders, debt funds, CMBS lenders, SBA lenders, and more. We have developed a flexible, two-sided, B2B marketplace that connects commercial borrowers and lenders, with a human touch. Commercial property owners, operators, and developers can quickly create an account on our platform, set up their own profile, and submit and manage loan requests on their dashboard in a digital experience. Our algorithms automatically match borrowers to their best loan options or to our internal capital markets advisors that guide the borrower throughout the process and connect them with a potentially suitable loan product and lender. Originators that work at commercial mortgage lenders can access their accounts on our platform to view, sort, and communicate with their matched borrowers in real-time, tracking their loan progress through our portal. Capital markets advisors that work internally have their own interface that gives them access to targeted loan opportunities empowering them to better assist borrowers in managing their choices, leading to the best possible outcomes for both lenders and borrowers while building trust, all of which is intended to enhance our brand. We believe that as we scale, we can use the same technology to provide similar services across the commercial property and small business value chain. Our mission is to remove frictions from traditional commercial property financing, making it easier and more cost-effective for all parties in the transaction. We intend to disintermediate commercial real estate financing, flattening the playing field for commercial property owners and developers, and lenders of all sizes, democratizing an otherwise fractured and elitist market. We were originally formed as Janover Ventures LLC, a Florida limited liability company, on November 28, 2018, and converted to Janover Inc., a Delaware corporation, on March 9, 2021. We are headquartered at 6401 Congress Avenue, Suite 250, Boca Raton, Florida.

Solana NASDAQ:HSDT

$2.46 -0.09 (-3.35%)

As of 10:58 AM Eastern

Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company was incorporated in 2014 and is headquartered in Newtown, Pennsylvania.

Lite Strategy NASDAQ:LITS

$1.25 -0.03 (-1.97%)

As of 10:59 AM Eastern

MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymphoma, as well as in Phase Ib multi-arm trial to treat B-cell malignancies; and Voruciclib, an oral cyclin-dependent kinase 9 inhibitor, which is in Phase Ib clinical trial for acute myeloid leukemia and B-cell malignancies. It also develops ME-344, a mitochondrial inhibitor targeting the oxidative phosphorylation complex that is in Phase I clinical trial for the treatment of human epidermal growth factor receptor 2 negative breast cancer; and Pracinostat, an oral available histone deacetylase inhibitor, which is in Phase II clinical trial to treat patients with myelodysplastic syndrome. MEI Pharma, Inc. has a license, development, and commercialization agreement with Kyowa Kirin Company; a clinical collaboration with BeiGene, Ltd.; a license, development, manufacturing, and commercialization agreement with Helsinn Healthcare SA; and a license agreement with Presage Biosciences, Inc. The company was formerly known as Marshall Edwards, Inc. and changed its name to MEI Pharma, Inc. in July 2012. MEI Pharma, Inc. was incorporated in 2000 and is headquartered in San Diego, California.

Upexi NASDAQ:UPXI

$1.06 -0.02 (-1.39%)

As of 11:00 AM Eastern

Upexi, Inc. manufactures and sells various branded products in the health, wellness, pet, beauty, and other markets. The company was formerly known as Grove, Inc. and changed its name to Upexi, Inc. in August 2022. The company was incorporated in 2018 and is headquartered in Clearwater, Florida.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest LITS, DFDV, HSDT, and UPXI Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest LITS, DFDV, HSDT, and UPXI Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

LITS, DFDV, HSDT, and UPXI Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

LITS, DFDV, HSDT, and UPXI Company Descriptions

DeFi Development NASDAQ:DFDV

Solana NASDAQ:HSDT

Lite Strategy NASDAQ:LITS

Upexi NASDAQ:UPXI

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest LITS, DFDV, HSDT, and UPXI Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest LITS, DFDV, HSDT, and UPXI Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

LITS, DFDV, HSDT, and UPXI Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

LITS, DFDV, HSDT, and UPXI Company Descriptions

DeFi Development NASDAQ:DFDV

Solana NASDAQ:HSDT

Lite Strategy NASDAQ:LITS

Upexi NASDAQ:UPXI

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools